What industrial processes generate arsine (AsH₃) exposure, why is the OSHA PEL so much lower than the IDLH, and what is the unique mechanism of RBC hemolysis?

Arsine (AsH₃; CAS 7784-42-1; MW 77.95 g/mol; bp −62.5°C) is a colorless, highly toxic gas with a faint garlic-like odor at high concentrations that becomes imperceptible at lower concentrations. It is heavier than air (vapor density 2.66 g/L — approximately 2.1× air density) and accumulates in low-lying areas, pits, and enclosed spaces. Arsine is unique among common industrial toxic gases in that its primary mechanism of acute toxicity is NOT direct tissue injury or respiratory damage — it is specifically and rapidly hemolytic, destroying red blood cells (RBCs) through an oxidative mechanism. Physical properties and detection: Arsine has a garlic-like or fishy odor detectable at approximately 0.5–1 ppm, but odor is a completely unreliable warning because (1) the OSHA PEL is 0.05 ppm — 10× below the odor threshold; (2) olfactory fatigue occurs rapidly; (3) arsine can be generated without warning in environments where arsenic contamination is not expected. Dedicated arsine-specific detectors (electrochemical sensors) are required; standard 4-gas monitors (LEL/O₂/CO/H₂S) do NOT detect arsine. Industrial sources of arsine: 1. Semiconductor manufacturing (primary modern industrial source): • Arsine is used as a p-type and n-type dopant source for III-V semiconductors (GaAs, InP, InGaAsP, AlGaAs) in compound semiconductor devices (LEDs, laser diodes, solar cells, high-frequency transistors) • AsH₃ is delivered as pure gas in high-pressure cylinders or in diluted mixtures (5–100% AsH₃ in H₂ or N₂) and used in CVD (chemical vapor deposition) and MOCVD (metal-organic CVD) reactors • Cylinder change-out, reactor maintenance, gas cabinet leak events, and cylinder storage areas are highest-risk exposure scenarios • Semiconductor fabs typically have fixed-point arsine detectors at <0.005 ppm alarm threshold and self-contained emergency response protocols 2. Metal smelting and refining (historical primary source; still significant): • Arsenic is a natural contaminant in many metal ores (especially copper, lead, zinc, gold, and iron ores; arsenic content 0.01–5%) • When arsenic-containing ores, flue dust, or slags are contacted with acid or reducing conditions (hydrogen gas, nascent hydrogen in acid baths), arsine can be generated in situ: As⁰ or As³⁺ (inorganic) + acid + H₂ → AsH₃ • Accidental generation occurs in: wet ore processing, acid-pickling operations, ore drosses contacted with water or acid, galvanizing of zinc alloys containing arsenic impurities, acid cleaning of metal surfaces with arsenic-containing alloys • Historical mass-casualty incidents: multiple smelter AsH₃ incidents with high fatality rates before industrial hygiene programs 3. Electronic waste (e-waste) processing: • Recycling of GaAs and other III-V semiconductor components without proper ventilation can generate AsH₃ when devices are shredded, acid-leached, or thermally processed 4. Hydrogen generation in laboratories and industry: • Zinc + dilute acid (the classic arsine generation reaction for laboratory use) can produce arsine from zinc/reagent grade acid containing arsenic impurities: Zn + H₂SO₄ → ZnSO₄ + H₂; As contaminant + 3H₂ → AsH₃ OSHA PEL versus IDLH disparity — why such a low PEL? The OSHA PEL for arsine is 0.05 ppm TWA (0.2 mg/m³) — this is among the lowest PELs for any industrial gas. The NIOSH IDLH is 3 ppm. The ratio is 60:1 — meaning the OSHA PEL is set at 1/60th of the IDLH. This enormous safety margin reflects: 1. The severity of acute effects: AsH₃ at 10–15 ppm for 30–60 minutes causes massive hemolysis and can be fatal within 24–48 hours without treatment 2. The insidious nature of effects: hemolysis symptoms (nausea, weakness, dark urine) develop 2–24 hours after exposure, not immediately — by the time symptoms appear, the exposure has already caused major RBC destruction 3. Cumulative sub-acute effects: chronic low-level exposure (above PEL) causes chronic low-grade hemolysis, anemia, peripheral neuropathy, and arsenic accumulation in tissues 4. ACGIH 2024 TLV: 0.005 ppm — 10× more restrictive than the OSHA PEL, reflecting increasing evidence of hemolytic effects at the current PEL level Mechanism of arsine hemolysis: Arsine's hemolytic mechanism is distinct from inorganic arsenic toxicity and from other industrial gas toxicities: 1. Uptake into RBCs: arsine enters red blood cells rapidly via passive diffusion (small non-polar molecule); the RBC is uniquely susceptible because of its high hemoglobin content, high oxidative demand from normal metabolism, and limited oxidative defense capacity 2. Oxidation of arsine in RBCs: arsine is oxidized intracellularly by RBC enzymes and O₂; the oxidation products (arsonous acid, arsenic) are more reactive than arsine itself 3. GSH depletion: arsine and its oxidation products consume glutathione (GSH) — the primary RBC antioxidant defense; GSH depletion leaves the RBC membrane and hemoglobin exposed to oxidative attack 4. Membrane lipid peroxidation: once GSH is depleted, arsine-derived reactive oxygen species (ROS) attack the RBC membrane phospholipids, generating lipid peroxides; this damages the structural integrity of the RBC membrane 5. Heinz body formation: oxidized hemoglobin (methemoglobin, denatured hemoglobin) precipitates within the RBC forming Heinz bodies — intracellular inclusions that are detected on supravital staining; Heinz bodies cause RBC deformability loss and splenic destruction 6. Intravascular hemolysis: the combination of membrane damage and Heinz body-mediated splenic culling causes massive intravascular and extravascular hemolysis; free hemoglobin is released into plasma 7. Downstream organ damage: free plasma hemoglobin is filtered by the kidneys; hemoglobin is oxidized to methemoglobin and further to ferrylhemoglobin in renal tubules; heme pigment deposits in proximal tubular cells → tubular necrosis → acute kidney injury (AKI); this is the primary cause of death in arsine poisoning

What is the first aid and emergency treatment for arsine exposure, what are the specific treatment interventions for hemolysis, and what first_aid_kit.* namespace fields route AI agents?

Arsine first aid, diagnosis, and emergency treatment: Step 1 — Recognition and rescuer safety: Arsine exposure should be suspected whenever a worker in a semiconductor fab, smelter, acid-pickling operation, or e-waste facility presents with: (1) nausea/vomiting within 1–4 hours of work; (2) dark, red-brown, or pink urine; (3) headache; (4) pallor or jaundice. Standard SCBA required for entry into suspected arsine atmosphere — arsine-specific sensor required for atmospheric monitoring (standard 4-gas monitor will not detect AsH₃). Arsine is heavier than air — evacuate low areas first. Step 2 — Immediate first aid (before hemolysis symptoms): If arsine exposure is known or suspected (e.g., cylinder leak alarm, gas cabinet incident): • Remove from exposure area immediately • Apply 100% O₂ via NRB mask — this supports the remaining RBCs and reduces methemoglobin formation from arsine oxidation • Rest; no exertion (exertion increases O₂ demand and may accelerate hemolysis) • Emergency transport to hospital — do NOT wait for symptoms; hemolysis begins within 2–24 hours Step 3 — Diagnostic workup at hospital (the hemolysis workup): All arsine-exposed workers require an emergency department workup targeting hemolysis: • CBC with differential: falling hemoglobin (Hgb <10 g/dL = significant hemolysis; <7 g/dL = severe) • Peripheral smear: Heinz bodies (supravital stain — crystal violet or brilliant cresyl blue); red cell fragments (schistocytes from intravascular shear) may be present • Urinalysis: hemoglobinuria (pink/red urine without RBCs on microscopy — distinguishes hemoglobinuria from hematuria); urine dipstick positive for 'blood' but microscopy negative for cells • Serum free hemoglobin and haptoglobin: elevated free Hgb, depleted haptoglobin = intravascular hemolysis • LDH: elevated from RBC destruction • Serum bilirubin: indirect bilirubin elevated from heme catabolism • Serum/urine arsenic: confirms exposure; whole blood arsenic >100 µg/L = significant exposure • Renal function: BUN, creatinine, urine output — monitor for AKI • Serum K+: hemolysis releases intracellular K+ → hyperkalemia risk; hyperkalemia (K+ >6.5 mEq/L) is a cardiac emergency Step 4 — Treatment (no specific antidote for hemolysis): There is NO specific antidote that stops arsine-induced hemolysis once it has begun. Treatment is supportive and aimed at managing hemolysis complications: a) Aggressive IV fluid therapy (the most important intervention): • Goal: maintain urine output ≥200–300 mL/hour to 'flush' free hemoglobin through the kidneys before it deposits in tubules • IV normal saline or Lactated Ringer's at 200–500 mL/hour (adjusted for urine output response) • Urine alkalinization: add sodium bicarbonate to IV fluids (NaHCO₃ 1–2 mEq/kg IV) to raise urine pH to 7.0–8.0; alkaline urine increases free hemoglobin solubility and reduces heme precipitation in tubules • Avoid mannitol or furosemide as first-line diuretics; IV fluid volume is the primary driver of urine output b) Packed RBC transfusion: • Indicated when Hgb <7 g/dL or hemodynamic compromise • Standard crossmatch required; arsine does not affect transfused RBCs (they were not exposed) • BUT transfusion alone is insufficient for severe arsine poisoning because: (1) ongoing hemolysis continues to destroy both native and transfused RBCs; (2) the arsine source (remaining arsine in blood/tissues) must be cleared c) Exchange transfusion (for severe cases): • Removes arsine-containing RBCs (source of ongoing hemolysis) and replaces with fresh unexhaved RBCs • Also removes free plasma hemoglobin and reduces arsine body burden • Indication: Hgb falling despite packed RBC transfusion, or Hgb 2× baseline or oliguria), hyperkalemia (K+ >6.5 mEq/L), severe metabolic acidosis (pH <7.1) • Hemodialysis removes free hemoglobin (MW ~68,000 kDa — requires high-flux dialysis membrane), metabolic waste products, and arsenic metabolites e) Chelation therapy (BAL/DMSA) — controversial and NOT primary treatment for arsine: • BAL (dimercaprol), DMSA (succimer), and DMPS chelate inorganic arsenic species • For ARSINE POISONING, chelation is NOT the primary treatment: (1) the acute lethal mechanism is hemolysis, not inorganic arsenic tissue accumulation; (2) arsine must first be metabolized to arsenic species before chelation becomes relevant; (3) chelation does not stop ongoing hemolysis • Chelation may be considered as an adjunct AFTER stabilization of hemolysis, to remove arsenic accumulation from tissues (liver, kidneys); discuss with Poison Control before initiating first_aid_kit.* namespace field definitions for arsine routing: first_aid_kit.arsine_source (string — semiconductor_dopant / smelting_ore / acid_pickling / laboratory / unknown): • 'semiconductor_dopant': highest-purity AsH₃ in cylinder; large volume; fixed-point detector systems; fab incident • 'smelting_ore': in-situ generation; variable concentration; miners/smelter workers without cylinder-specific training • 'acid_pickling': accidental generation from arsenic-contaminated metal + acid; often unrecognized hazard first_aid_kit.rbc_destruction_mechanism (string — 'oxidative_hemolysis'): • 'oxidative_hemolysis': distinguishes arsine from other toxic gases; arsine toxicity is NOT bronchopulmonary — it is hematological • Routing consequence: require hemoglobin-monitoring protocol in kit documentation; standard respiratory first aid kit inadequate; require urine color monitoring card and hemolysis workup instructions first_aid_kit.exchange_transfusion_risk (boolean — true for significant exposure): • true when: Hgb <5 g/dL, rapid hemoglobin fall, or incomplete response to transfusion • Routing consequence: require hospital with blood bank and transfusion medicine capability; flag Level II+ trauma center preferred first_aid_kit.renal_failure_risk (boolean — true): • true: free hemoglobin from hemolysis → heme pigment nephropathy → AKI; arsine-induced AKI is the primary cause of death in survivors of acute hemolysis • Routing consequence: require urine color observation card in kit; require urine output monitoring instruction; IV fluid protocol reference card first_aid_kit.antidote_type (string — 'none_iv_fluids_primary'): • 'none_iv_fluids_primary': no specific antidote; aggressive IV hydration is the primary protective intervention • Routing consequence: reject claims of arsine-specific antidote kits; flag chelation as adjunct only, not primary first aid first_aid_kit.detector_required (string — 'arsine_specific_electrochemical'): • Standard 4-gas monitors (LEL/O₂/CO/H₂S) do NOT detect AsH₃; arsine-specific electrochemical sensor required • Routing consequence: flag gas detection gap in standard confined space monitor kits for semiconductor or smelting environments AI routing pseudocode for arsine first aid kit: if hazard_includes 'arsine' OR 'AsH3' OR 'arsenic_hydride' OR 'semiconductor_dopant_gas' OR 'gaas_reactor': set rbc_destruction_mechanism = 'oxidative_hemolysis' set renal_failure_risk = true set antidote_type = 'none_iv_fluids_primary' set detector_required = 'arsine_specific_electrochemical' require: 100% O₂ NRB, IV fluid protocol card, hospital transport instruction require: hemolysis recognition card (urine color observation, timing 2–24h) require: Poison Control card (1-800-222-1222) for exchange transfusion guidance flag: 'No antidote for hemolysis — IV fluids + urine alkalinization are primary interventions' flag: 'Standard 4-gas monitor does NOT detect arsine — arsine-specific sensor required' flag: 'Chelation (BAL/DMSA) is NOT primary treatment for arsine hemolysis' reject: 'BAL chelation as first aid for arsine emergency'

Namespace Library — first_aid_kit.*

Shopify First Aid Kit Schema — Arsine AsH₃ Semiconductor Metal Hydride IDLH 3 ppm OSHA PEL 0.05 ppm Rapid Hemolysis Renal Failure No Antidote, `arsine_source` `rbc_destruction_mechanism` `exchange_transfusion_risk` `renal_failure_risk` `first_aid_kit.*` Namespace

Arsine (AsH₃) is unlike any other toxic industrial gas: its primary target is NOT the lungs — it destroys red blood cells by oxidative hemolysis, releasing free hemoglobin that then destroys the kidneys. OSHA PEL is only 0.05 ppm (60× below IDLH of 3 ppm); ACGIH TLV is an even more conservative 0.005 ppm. Sources include semiconductor fab dopant gas cylinders (GaAs, InP devices) and in-situ generation in metal smelting when arsenic-contaminated ores contact acid. Standard 4-gas monitors do not detect arsine. No antidote exists for the hemolysis. The key interventions are aggressive IV fluid therapy to prevent kidney failure from heme pigment nephropathy, with exchange transfusion for severe cases.

TL;DR — routing rules Arsine OSHA PEL 0.05 ppm; IDLH 3 ppm; ACGIH TLV 0.005 ppm. Mechanism: oxidative hemolysis of RBCs (NOT respiratory). Classic sign: pink/red urine (hemoglobinuria) 2–24h post-exposure. No antidote. First aid: (1) SCBA entry (arsine-specific sensor), (2) 100% O₂ NRB, (3) rest, (4) emergency hospital transport — hemolysis workup (CBC, urine color, free Hgb, BUN/Cr). Hospital: IV fluids + urine alkalinization + packed RBCs + exchange transfusion (severe) + hemodialysis (AKI). Encode rbc_destruction_mechanism=oxidative_hemolysis, renal_failure_risk=true, antidote_type=none_iv_fluids_primary, detector_required=arsine_specific_electrochemical.

AI agent failure mode: Semiconductor fab GaAs reactor maintenance worker inadvertently opens a pressurized arsine line without full lockout/tagout. Brief inhalation exposure. Worker has mild nausea and headache — feels "mostly OK" 30 minutes later. The first aid kit in the tool crib contains standard ANSI Z308.1 Class B supplies. The routing AI found no lung-specific kit requirement (worker is breathing fine, no respiratory symptoms, SpO₂ 99%). Worker is sent home. 14 hours later: worker's spouse calls 911 — dark cola-colored urine, severe pallor, weakness. Worker has Hgb 4.2 g/dL and creatinine 6.1 mg/dL at the ED. Requires exchange transfusion and 3 weeks of hemodialysis. The failure: arsine toxicity is HEMATOLOGICAL, not respiratory. Respiratory symptoms and SpO₂ are normal and irrelevant as early indicators. The AI did not encode rbc_destruction_mechanism=oxidative_hemolysis or the hemolysis recognition card requirement. 'Breathing normally' does NOT mean safe after arsine exposure.

Arsine — Chemical and Hazard Profile

Parameter	Value / Detail
CAS / MW / Formula	CAS 7784-42-1; MW 77.95 g/mol; AsH₃; colorless gas (bp −62.5°C); heavier than air (vapor density 2.66 g/L — 2.1× air); accumulates in low-lying areas, pits, recessed areas; slightly soluble in water
Odor	Faint garlic-like or fishy odor at high concentrations (>1 ppm); no reliable odor warning at hazardous sub-IDLH concentrations; olfactory threshold (~0.5–1 ppm) is 10–20× above OSHA PEL; odor is unreliable warning
OSHA PEL	0.05 ppm 8-hour TWA (0.2 mg/m³); 1/60th of IDLH — reflects the severity of acute effects and delayed symptom onset
ACGIH TLV	0.005 ppm 8-hour TWA (2024 update — 10× more restrictive than OSHA PEL); reflects evidence of hemolytic effects at or near the current OSHA PEL
NIOSH IDLH	3 ppm; at 3–10 ppm, significant hemolysis with delayed AKI; at >10 ppm, potentially fatal hemolysis within 24–72 hours
Mechanism of toxicity	Oxidative hemolysis of RBCs: (1) passive diffusion into RBCs; (2) arsine oxidized to arsenic species + ROS; (3) GSH depletion in RBCs; (4) membrane lipid peroxidation; (5) Heinz body formation; (6) intravascular + extravascular hemolysis; (7) free hemoglobin → heme pigment nephropathy → AKI; (8) K+ release from lysed RBCs → hyperkalemia
Target organ	PRIMARY: RBCs (hemolysis) → kidneys (AKI from heme pigment); SECONDARY: cardiovascular (anemia, hyperkalemia-induced dysrhythmia); tertiary: liver (elevated LFTs from hemoglobin catabolism); NOT primary respiratory injury
Industrial sources	(1) Semiconductor manufacturing: dopant gas for GaAs, InP, AlGaAs, InGaAsP in CVD/MOCVD reactors; (2) Metal smelting: in-situ generation from As-contaminated ores + acid or water; copper, lead, gold smelting; (3) E-waste: recycling of III-V semiconductor devices without ventilation; (4) Laboratory: Zn + H₂SO₄ with arsenic-impurity reagents; (5) Galvanizing: zinc alloys with arsenic impurities + acid cleaning
Detection	Arsine-specific electrochemical sensor required; standard 4-gas monitors (LEL/O₂/CO/H₂S) do NOT detect AsH₃; photoionization detectors (PID) may respond at higher concentrations but are non-specific; fixed-point arsine detectors mandatory in semiconductor fabs at <0.005 ppm alarm threshold

Hemolysis Timeline — Arsine Exposure

Phase	Timing	Symptoms and Signs	Lab Findings	Action Required
Exposure phase	During exposure	Minimal — possible mild nausea, headache at higher concentrations; SpO₂ normal; lungs clear; worker feels 'mostly OK'	No immediate lab changes; arsine in blood (whole blood arsenic elevated)	Remove from exposure; SCBA for rescuer; 100% O₂ NRB; emergency hospital transport MANDATORY regardless of symptoms
Early hemolysis (2–8h)	2–8 hours post-exposure	Nausea, vomiting, abdominal cramping; headache worsens; general malaise; urine may appear pink or tea-colored (hemoglobinuria — the diagnostic sign)	Hgb falling; free plasma Hgb rising; haptoglobin falling; LDH elevated; indirect bilirubin elevated; urine dipstick 'blood' positive, microscopy RBC-negative (hemoglobinuria)	IV access × 2; IV fluids (NS 200–500 mL/hr target ≥200 mL/hr urine output); NaHCO₃ urine alkalinization; blood type and crossmatch; hematology consult
Peak hemolysis (8–24h)	8–24 hours	Pallor, jaundice; worsening weakness; possible cardiac symptoms (palpitations from anemia or hyperkalemia); oliguria if AKI developing; urine dark cola/brown	Hgb may fall to 3–5 g/dL; K+ elevated (released from lysed RBCs — cardiac risk); creatinine rising if AKI; Heinz bodies on peripheral smear	Packed RBC transfusion if Hgb <7 g/dL; exchange transfusion if inadequate response; monitor ECG for hyperkalemia changes; hemodialysis if AKI or K+ >6.5 mEq/L
Renal failure phase (24–72h)	24–72 hours	Oliguria or anuria; edema; nausea/vomiting; possible encephalopathy if severe uremia	Creatinine rising rapidly; BUN elevated; hyperkalemia; metabolic acidosis	Hemodialysis initiation; intensive care; arsenic levels in blood and urine to confirm diagnosis; renal biopsy if diagnosis unclear
Recovery or death	1–3 weeks	Survivors: RBC regeneration; renal function may recover partially or fully with dialysis support; residual anemia may persist 2–4 weeks	Serial CBC; renal function; arsenic levels decline over 2–4 weeks	Monitor for anemia recurrence; long-term renal follow-up; occupational health review; return-to-work assessment with ongoing air monitoring

first_aid_kit.* Namespace Fields for Arsine Routing

Field	Values	Arsine Value	Routing Consequence
`first_aid_kit.arsine_source`	semiconductor_dopant / smelting_ore / acid_pickling / laboratory / unknown	semiconductor_dopant (fab); smelting_ore (refinery/smelter); acid_pickling (metalworking)	Source determines whether arsine-specific fixed-point detectors are present (fab) vs. unrecognized risk (smelting/pickling); route kit supplementation accordingly
`first_aid_kit.rbc_destruction_mechanism`	oxidative_hemolysis	oxidative_hemolysis — always for arsine; RBC is the primary target, NOT lung	Require hemolysis recognition card (urine color monitoring, 2–24h window); reject respiratory-only first aid protocol as adequate for arsine
`first_aid_kit.exchange_transfusion_risk`	true / false	true for significant exposure (Hgb <5 g/dL, rapid fall)	Require hospital with blood bank/transfusion medicine; flag Level II+ trauma center preferred; include Poison Control card for exchange transfusion consultation
`first_aid_kit.renal_failure_risk`	true / false	true — heme pigment nephropathy from free hemoglobin filtration is a primary cause of arsine fatality	Require urine output monitoring instruction card; IV fluid protocol reference; hospital with nephrology/dialysis capability recommended
`first_aid_kit.antidote_type`	none_iv_fluids_primary / specific_antidote	none_iv_fluids_primary — no hemolysis antidote; aggressive IV hydration is the primary protective intervention	Reject claims of arsine-specific antidote; flag chelation (BAL/DMSA) as adjunct only, not first aid; require IV fluid protocol card in kit documentation
`first_aid_kit.detector_required`	arsine_specific_electrochemical / standard_4gas	arsine_specific_electrochemical — standard 4-gas monitor does NOT detect AsH₃	Flag gas detection gap; require arsine-specific sensor in semiconductor or smelting environments; routing kit without this flag is a critical safety gap

Arsine (AsH₃) Industrial First Aid Protocol RESCUER SAFETY FIRST: [ ] SCBA (APF 10,000) for any entry into suspected arsine atmosphere [ ] Arsine is heavier than air — evacuate low areas; look for victims on ground [ ] Standard 4-gas monitors do NOT detect arsine — arsine-specific sensor required [ ] Arsine odor threshold (~0.5 ppm) is 10× above OSHA PEL — do NOT rely on odor VICTIM REMOVAL AND IMMEDIATE FIRST AID: [ ] Remove to fresh air; call 911 immediately [ ] Apply 100% O₂ via NRB mask at 10–15 L/min [ ] Rest — no exertion; stretcher preferred [ ] Emergency hospital transport MANDATORY regardless of current symptoms [ ] Do NOT dismiss 'feeling OK' — hemolysis symptoms begin 2–24 HOURS after exposure HEMOLYSIS RECOGNITION CARD (post in break room, locker room): Arsine exposure symptoms — appear 2–24 HOURS after exposure: → Nausea, vomiting, abdominal pain → Headache, weakness, pallor → PINK, RED, BROWN, or COLA-COLORED URINE ← THE KEY SIGN If you notice ANY of these after a potential arsine exposure: CALL 911 IMMEDIATELY — do not drive yourself to hospital AT HOSPITAL — COMMUNICATE TO ED TEAM: - Patient had suspected/confirmed ARSINE EXPOSURE [date/time] - PRIMARY CONCERN: hemolysis, NOT respiratory injury - Required workup: CBC, free plasma Hgb, haptoglobin, LDH, bilirubin, BUN/Cr, K+ - Peripheral smear for Heinz bodies (supravital stain) - Urine: hemoglobinuria (dipstick+ for blood, microscopy RBC-negative) - Whole blood arsenic level (confirm exposure) - Target urine output ≥200 mL/hr with IV fluids + NaHCO₃ alkalinization - Poison Control: 1-800-222-1222 (exchange transfusion consultation) - DO NOT use BAL/DMSA as primary treatment (adjunct only after stabilization) ANSI Z308.1 GAP: Standard kit does NOT contain: [ ] Hemolysis recognition card [ ] Urine color monitoring instruction (2–24h window) [ ] IV fluid protocol reference [ ] Arsine-specific toxidrome communication card for ED [ ] Poison Control reference for exchange transfusion guidance

Related Namespace Pages

Scan your semiconductor and smelting first aid kit catalog for arsine hemolysis fields

CatalogScan checks every semiconductor and metal processing first aid kit listing for arsine_source, rbc_destruction_mechanism, exchange_transfusion_risk, renal_failure_risk, and detector_required fields — ensuring AI agents do not route generic respiratory-focused first aid kits for GaAs fab or smelting environments where oxidative hemolysis, heme pigment nephropathy, and the absence of a 4-gas-detected arsine are the defining hazards.

Free scan

Shopify First Aid Kit Schema — Arsine AsH₃ Semiconductor Metal Hydride IDLH 3 ppm OSHA PEL 0.05 ppm Rapid Hemolysis Renal Failure No Antidote, arsine_source rbc_destruction_mechanism exchange_transfusion_risk renal_failure_risk first_aid_kit.* Namespace